Literature DB >> 15080383

The prevalence of known diabetes in eight European countries.

D M Fleming1, F G Schellevis, V Van Casteren.   

Abstract

BACKGROUND: The prevalence of diabetes has been proposed as a European Community Health Indicator. The prevalence of diabetes known to general practitioners (GPs) in different European countries has been investigated and the usefulness of sentinel practice networks in delivering prevalence data on diabetes has been evaluated.
METHODS: Patients presenting with diabetes in a 12 month period (1999/2000) to GPs in established European sentinel practice surveillance networks in eight European countries were registered. Estimates of prevalence were standardized to the 1998 European population.
RESULTS: All-age prevalence reported in the network populations was lowest in Slovenia (male 16, female 16 per 1000) and highest in Belgium (male 31, female 34). The range of estimates obtained in this study was narrower than that published by the WHO in the Health For All database. The range was further reduced by age standardization. In males aged 45 years and over, age standardized prevalence ranged from 39 (Slovenia) to 76 (Belgium) and in females from 37 (Slovenia) to 75 (Belgium). There were no consistent gender differences in national prevalence rates.
CONCLUSIONS: The study demonstrates the capacity of sentinel practice networks to deliver data on the prevalence of known diabetes in persons over 45 years. National differences in prevalence are less than hitherto reported. Prevalence in Belgium measured in all ages and in 45 years and over males and females was higher than in the seven other countries.

Entities:  

Mesh:

Year:  2004        PMID: 15080383     DOI: 10.1093/eurpub/14.1.10

Source DB:  PubMed          Journal:  Eur J Public Health        ISSN: 1101-1262            Impact factor:   3.367


  20 in total

1.  Recent changes in the prevalence of diseases presenting for health care.

Authors:  Douglas M Fleming; Kenneth W Cross; Michele A Barley
Journal:  Br J Gen Pract       Date:  2005-08       Impact factor: 5.386

Review 2.  Risk factors for cardiovascular disease and hormone therapy in women.

Authors:  P Collins
Journal:  Heart       Date:  2006-05       Impact factor: 5.994

3.  Yield of opportunistic targeted screening for type 2 diabetes in primary care: the diabscreen study.

Authors:  Erwin P Klein Woolthuis; Wim J C de Grauw; Willem H E M van Gerwen; Henk J M van den Hoogen; Eloy H van de Lisdonk; Job F M Metsemakers; Chris van Weel
Journal:  Ann Fam Med       Date:  2009 Sep-Oct       Impact factor: 5.166

4.  Prescribing Trends of Codeine-containing Medications and Other Opioids in Primary Care After A Regulatory Decision: An Interrupted Time Series Analysis.

Authors:  Niccolò Lombardi; Alfredo Vannacci; Alessandra Bettiol; Ettore Marconi; Serena Pecchioli; Alberto Magni; Claudio Cricelli; Francesco Lapi
Journal:  Clin Drug Investig       Date:  2019-05       Impact factor: 2.859

5.  Incidence and management of presumption of Lyme borreliosis in Belgium: recent data from the sentinel network of general practitioners.

Authors:  K Vanthomme; N Bossuyt; N Boffin; V Van Casteren
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-03-06       Impact factor: 3.267

6.  Sexual behaviour, sexual dysfunctions and related help seeking patterns in middle-aged and elderly Europeans: the global study of sexual attitudes and behaviors.

Authors:  Alfredo Nicolosi; Jacques Buvat; Dale B Glasser; Uwe Hartmann; Edward O Laumann; Clive Gingell
Journal:  World J Urol       Date:  2006-07-19       Impact factor: 4.226

7.  Physician reports of medication use with explicit intention of hastening the end of life in the absence of explicit patient request in general practice in Belgium.

Authors:  Koen Meeussen; Lieve Van den Block; Nathalie Bossuyt; Michael Echteld; Johan Bilsen; Luc Deliens
Journal:  BMC Public Health       Date:  2010-04-09       Impact factor: 3.295

8.  Vascular outcomes in patients with screen-detected or clinically diagnosed type 2 diabetes: Diabscreen study follow-up.

Authors:  Erwin P Klein Woolthuis; Wim J C de Grauw; Susanne M van Keeken; Reinier P Akkermans; Eloy H van de Lisdonk; Job F M Metsemakers; Chris van Weel
Journal:  Ann Fam Med       Date:  2013 Jan-Feb       Impact factor: 5.166

9.  GPs' awareness of patients' preference for place of death.

Authors:  Koen Meeussen; Lieve Van den Block; Nathalie Bossuyt; Johan Bilsen; Michael Echteld; Viviane Van Casteren; Luc Deliens
Journal:  Br J Gen Pract       Date:  2009-09       Impact factor: 5.386

10.  Estimating and comparing incidence and prevalence of chronic diseases by combining GP registry data: the role of uncertainty.

Authors:  Pieter H van Baal; Peter M Engelfriet; Rudolf T Hoogenveen; Marinus J Poos; Catharina van den Dungen; Hendriek C Boshuizen
Journal:  BMC Public Health       Date:  2011-03-15       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.